2015 L6 Case 5 Car Crash Guy

Overview of Blood Groups and Physiology

  • Discussion focused on blood groups and the physiological principles behind blood transfusion protocols.

  • Case study of a patient experiencing severe blood loss after a traumatic incident in a car crash.

Blood Loss and its Implications

  • Patient characteristics: young male who is unconscious and has lost 40% of total blood volume.

  • Resulting hypotension and increased risk of hypovolemic shock due to significant blood loss

    • Hypovolemic Shock: Inefficient delivery of oxygenated blood to organs, risking organ failure.

    • Lack of patient identification complicates treatment and risk assessment, especially regarding previous transfusions and allergies.

Risks of Blood Transfusion

  • Blood transfusions are routine but not without risks; transferring human tissue imposes potential hazards.

  • Internal injuries from trauma can lead to electrolyte imbalances, possibly affecting central nervous system function.

  • Spleen Damage: Highly vascular organ crucial for red blood cell quality control; trauma can lead to heavy internal bleeding.

  • Disseminated Intravascular Coagulation (DIC): Potential condition where a cascade of clotting occurs throughout the body, resulting in small clots and post-clotting bleeding risk.

    • DIC can lead to severe hemorrhaging after initial clotting reactions.

Initial Patient Management

  • Focus on hemodynamic stability: stem blood loss and restore blood volume.

  • Trauma Response Protocol: Multi-pronged approach including:

    • Administering agents to promote clotting (e.g., tranexamic acid, fresh frozen plasma).

    • Administering saline for volume restoration to increase blood pressure, especially critical during acute emergencies.

  • Packed Red Cells: Used sparingly; only when oxygen delivery is compromised due to lost hemoglobin capacity.

Tranexamic Acid

  • Tranexamic acid is an antifibrinolytic agent that inhibits plasminogen activation, helping to stabilize clots.

  • Used in various scenarios, including postpartum hemorrhage and trauma.

Components of Blood Transfusion

  • In the UK, blood transfusions typically involve packed red cells, not whole blood.

  • Blood donation leads to fractionation into components (red cells, plasma, and platelets).

  • White blood cells are typically discarded due to risk of immune reactions.

Blood Composition and Measurement

  • Average adult has about 5 liters of blood with distinct components:

    • Plasma (over half), red blood cells (just under half), and very small amounts of platelets and white blood cells.

  • Specific transfusion criteria:

    • Blood transfusion considered when over a third of blood volume is lost or hemoglobin levels drop below 80 g/L.

Historical Context

  • Blood group discovery by Karl Landsteiner in 1901 (ABO system) essential for safe transfusions.

  • Early blood transfusions were carried out with minimal understanding, leading to fatalities.

  • Blood banking practices evolved significantly during wartime, leading to modern systems of blood storage and transfusion.

ABO Blood Group System

  • Comprises four primary groups: A, B, AB, and O based on antigen presence on red blood cells.

  • Genetic Inheritance: Dominant and recessive alleles govern blood group formation.

  • Rh Factor: Presence of D antigen significantly impacts transfusion compatibility.

Blood Group Compatibility Table

  • Summary of blood type compatibility for transfusion:

    • A: Can receive A and O

    • B: Can receive B and O

    • AB: Universal recipient (A, B, AB, O)

    • O: Universal donor, but can only receive O

    • Rh positive individuals can receive Rh negative blood, while Rh negative individuals can only receive Rh negative blood.

Patient Testing and Safety Procedures

  • Blood typing involves both forward (antigens) and reverse (antibodies) group testing.

  • A rigorous process is necessary to prevent transfusion reactions.

Transfusion Reactions Risks and Management

  • Acute hemolytic transfusion reactions can occur if antibodies react with mismatched blood.

  • Symptoms include hematuria, fever, and potential acute kidney injury. Early detection is critical for patient safety.

  • Vigilant monitoring is required throughout the transfusion process.

Plasma Products and Emerging Techniques

  • Plasma provides essential coagulation factors; procurement influenced by historical issues (HIV, hepatitis transmissions in the '70s and '80s).

  • Recent innovations aim to ensure blood supply integrity and safety for patients, including matching donor and recipient factors.

  • Challenges in plasma safety continue with prion disease risks affecting donor eligibility criteria.

Conclusion

  • Continuous education and public health initiatives are critical to maintaining adequate blood supplies, especially across diverse populations.

  • The evolution of blood transfusion protocols demonstrates an ongoing commitment to patient safety and care.